These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 478046)

  • 41. Intra-arterially administered reserpine and saline in scleroderma.
    Siegel RC; Fries JF
    Arch Intern Med; 1974 Sep; 134(3):515-8. PubMed ID: 4604627
    [No Abstract]   [Full Text] [Related]  

  • 42. Observational data to study medication outcomes in systemic sclerosis.
    Hudson M; Baron M; ; Steele R
    J Rheumatol; 2011 Mar; 38(3):575-7. PubMed ID: 21362793
    [No Abstract]   [Full Text] [Related]  

  • 43. [Corticostesteroids in the treatment of scleroderma].
    Szczepański A
    Przegl Dermatol; 1971; 58(6):749-53. PubMed ID: 5139315
    [No Abstract]   [Full Text] [Related]  

  • 44. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS; Gilgor RS; Allen LM; Duvic M
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.
    Beckett VL; Conn DL; Fuster V; Osmundson PJ; Strong CG; Chao EY; Chesebro JH; O'Fallon WM
    Arthritis Rheum; 1984 Oct; 27(10):1137-43. PubMed ID: 6386002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
    Clegg DO; Reading JC; Mayes MD; Seibold JR; Harris C; Wigley FM; Ward JR; Pisko EJ; Weisman MH; Lee P
    J Rheumatol; 1994 Jan; 21(1):105-10. PubMed ID: 8151563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.
    Casas JA; Saway PA; Villarreal I; Nolte C; Menajovsky BL; Escudero EE; Blackburn WD; Alarcón GS; Subauste CP
    Ann Rheum Dis; 1990 Nov; 49(11):926-8. PubMed ID: 2256740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The course of scleroderma following treatment with carnitin].
    Nitzschner H
    Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
    [No Abstract]   [Full Text] [Related]  

  • 49. [Colchicine therapy in liver cirrhosis].
    Poralla T
    Z Gastroenterol; 1989 Jan; 27(1):10-2. PubMed ID: 2646837
    [No Abstract]   [Full Text] [Related]  

  • 50. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study.
    Deftereos S; Giannopoulos G; Kossyvakis C; Efremidis M; Panagopoulou V; Kaoukis A; Raisakis K; Bouras G; Angelidis C; Theodorakis A; Driva M; Doudoumis K; Pyrgakis V; Stefanadis C
    J Am Coll Cardiol; 2012 Oct; 60(18):1790-6. PubMed ID: 23040570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of pustulosis palmaris et plantaris with colchicine. A double-blind cross-over trial.
    Thestrup-Pedersen K; Reymann F
    Acta Derm Venereol; 1984; 64(1):76-8. PubMed ID: 6203289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of subcutaneous calcinosis in systemic disorders].
    Bienvenu B
    Rev Med Interne; 2014 Jul; 35(7):444-52. PubMed ID: 24880741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclofenil versus placebo in progressive systemic sclerosis. A one-year double-blind crossover study of 27 patients.
    Blom-Bülow B; Oberg K; Wollheim FA; Persson B; Jonson B; Malmberg P; Boström H; Herbai G
    Acta Med Scand; 1981; 210(5):419-28. PubMed ID: 7039242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A controlled trial of the effect of topical glyceryl trinitrate on skin blood flow and skin elasticity in scleroderma.
    Herrick AL; Gush RJ; Tully M; Jayson MI
    Ann Rheum Dis; 1994 Mar; 53(3):212. PubMed ID: 8154944
    [No Abstract]   [Full Text] [Related]  

  • 55. Heterotopic ossification in systemic sclerosis.
    Botzoris VG; Argyropoulou MI; Voulgari PV; Zikou AK; Drosos AA
    Scand J Rheumatol; 2009; 38(4):317-9. PubMed ID: 19337947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous colchicine for low-back pain: a double-blind study.
    Simmons JW; Harris WP; Koulisis CW; Kimmich SJ
    Spine (Phila Pa 1976); 1990 Jul; 15(7):716-7. PubMed ID: 2145645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progressive systemic sclerosis.
    Medsger TA
    Clin Rheum Dis; 1983 Dec; 9(3):655-70. PubMed ID: 6360519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic effect of d-penicillamine in scleroderma].
    Bogdanikowa B; Rudy J; Bernacka K; Palka Z
    Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401
    [No Abstract]   [Full Text] [Related]  

  • 59. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
    Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [EFFICACY OF CERTAIN DERIVATIVES OF COLCHICINE IN THE TREATMENT OF SCLERODERMIC SYNDROMES].
    HOUSSET E
    Angeiologie; 1964; 16():23. PubMed ID: 14246129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.